| 发明名称 |
Crystalline Bortezomib process |
| 摘要 |
The present invention provides process for preparation of crystalline Bortezomib (Ia) as its monohydrate which is designated as crystalline Form-SB (Ia) and characterized by having water content ranging between 3.5 - 6.0 % |
| 申请公布号 |
AU2013346322(B2) |
申请公布日期 |
2016.11.10 |
| 申请号 |
AU20130346322 |
申请日期 |
2013.11.12 |
| 申请人 |
Shilpa Medicare Limited |
发明人 |
Shrawat, Vimal Kumar;Rafiuddin;Singh, Vinod Kumar;Chaturvedi, Akshay Kant |
| 分类号 |
A61K31/517;A61K31/60;C07F5/02;C07F5/04 |
主分类号 |
A61K31/517 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
